DUB

Deubiquitinase (DUB) inhibitors block enzymes that remove ubiquitin from substrate proteins and edit ubiquitin chains. A 2005 inventory catalogued the deubiquitinating enzymes encoded in the human genome and reviewed their functions. Most are cysteine proteases, such as the ubiquitin-specific proteases (USPs) and ubiquitin C-terminal hydrolases (UCHs). IU1, reported in 2010, inhibits the proteasome-associated USP14 and enhances proteasome activity in cells. b-AP15 blocks USP14 and ubiquitin C-terminal hydrolase L5 (UCHL5) at the 19S regulatory particle of the proteasome. PR-619 is a broad-spectrum DUB inhibitor, ML364 targets USP2, and LDN-57444 targets UCH-L1. GRL0617 inhibits the papain-like protease (PLpro) of the severe acute respiratory syndrome (SARS) coronavirus, which also acts as a viral DUB.

1 Item

  • USP7 activator 1
    Cat. No.
    A54520

    USP7 activator 1

    USP7 activator 1 is a small molecule that specifically activates the deubiquitinating enzyme USP7 by binding to its allosteric C-terminal pocket. This compound enhances USP7's enzymatic activity, which is crucial for regulating protein stability and cellular processes. It is valuable for research applications focused on protein degradation, viral interactions, and cancer biology, enabling the study of USP7’s role in various signaling pathways and disease mechanisms.

    5 mg
    $795.00
    10 mg
    $1,175.00
    All 4 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...